Optimised cell culture development for pharma, biotech, CMOs and media providers
Dr Sasa Stojkovic | Head of Pilot Bioprocess Department Sandoz
Dr. Sasa Stojkovic (36) is heading the bioprocess pilot department at the Sandoz Biopharmaceuticals Business Unit at Lek Pharmaceuticals in Menges, Slovenia, which is responsible for the bioprocess development, scale up and process transfer to clinical material production of mammalian proteins. Before that he has done his PhD on probiotic bacteria research at Biotechnical faculty at University of Ljubljana, and later he held a position of Scientist at Lek Pharmaceuticals in Menges, Slovenia, responsible for process transfer, scale up and clinical production of Binocrit, biosimilar recombinant hEPO.
Share this
Appearances at this years' conference:
DAY 2 - Wednesday 29th February 2012
@ 09.00
Chairman’s opening remarks
› Dr Sasa Stojkovic, Head of Pilot Bioprocess Department, Sandoz
Day 3 - Thursday 1st March 2012
@ 11.40
Exploring strategies to improve control and reduce variability
Designing a scale-up process which delivers consistency to prevent the need for extensive redevelopment at such a late downstream stage
Highlighting the need for technologies which can monitor parameters throughout bioproduction to allow increased control and understanding of the process
Developing a systematic approach to reduce and control process variability
› Dr Sasa Stojkovic, Head of Pilot Bioprocess Department, Sandoz